standard-title
Cilostazol Tablets IP 100mg Manufacturers, Suppliers & Exporters India – Taj Pharma {GMP Approved} Taj Pharma is WHO-GMP Certified Pharmaceutical Wholesaler of Cilostazol Tablets IP 100mg, Cilostazol Tablets IP 100mg Supplier, Cilostazol Tablets IP 100mg Exporters from India. Taj Pharma holds excellent record in manufacturing of Cilostazol Tablets IP 100mg from India. Find here Cilostazol Tablets IP 100mg FDA approved, Cilostazol Tablets IP 100mg manufacturers, suppliers & exporters in India. Get contract manufacturing for Cilostazol Tablets IP 100mg, Find best price for Cilostazol Tablets IP 100mg generic drug and Cilostazol Tablets IP 100mg generic version available at best price from GMP approved manufacturer Cilostazol Tablets IP 100mg manufacturers & Cilostazol Tablets IP 100mg suppliers in India. Taj Pharmaceuticals, the well-known Cilostazol Tablets IP 100mg manufacturer in India gives the assurance of high-quality and purity. The company carries the rich experience in manufacturing of Cilostazol Tablets IP 100mg. Taj Pharmaceuticals is reputed manufacturer and Cilostazol Tablets IP 100mg suppliers from India. Get contact for Cilostazol Tablets IP 100mg manufacturing companies from India. Taj Pharmaceuticals, the well-known Cilostazol Tablets IP 100mg Manufacturer in India gives the assurance of high-quality and purity. The company carries the rich experience in the niche manufacturing of Cilostazol Tablets IP 100mg. Taj Pharmaceuticals is reputed manufacturer and Cilostazol Tablets IP 100mg suppliers in India.
Cilostazol Tablets IP 100mg Manufacturers, Suppliers & Exporters India – Taj Pharma {GMP Approved}
Taj Pharma is WHO-GMP Certified Pharmaceutical Wholesaler of Cilostazol Tablets IP 100mg, Cilostazol Tablets IP 100mg Supplier, Cilostazol Tablets IP 100mg Exporters from India. Taj Pharma holds excellent record in manufacturing of Cilostazol Tablets IP 100mg from India. Find here Cilostazol Tablets IP 100mg FDA approved, Cilostazol Tablets IP 100mg manufacturers, suppliers & exporters in India. Get contract manufacturing for Cilostazol Tablets IP 100mg, Find best price for Cilostazol Tablets IP 100mg generic drug and Cilostazol Tablets IP 100mg generic version available at best price from GMP approved manufacturer Cilostazol Tablets IP 100mg manufacturers & Cilostazol Tablets IP 100mg suppliers in India. Taj Pharmaceuticals, the well-known Cilostazol Tablets IP 100mg manufacturer in India gives the assurance of high-quality and purity. The company carries the rich experience in manufacturing of Cilostazol Tablets IP 100mg. Taj Pharmaceuticals is reputed manufacturer and Cilostazol Tablets IP 100mg suppliers from India. Get contact for Cilostazol Tablets IP 100mg manufacturing companies from India. Taj Pharmaceuticals, the well-known Cilostazol Tablets IP 100mg Manufacturer in India gives the assurance of high-quality and purity. The company carries the rich experience in the niche manufacturing of Cilostazol Tablets IP 100mg. Taj Pharmaceuticals is reputed manufacturer and Cilostazol Tablets IP 100mg suppliers in India.
GENERIC NAME OF THE MEDICINAL PRODUCT:
Cilostazol Tablets IP 50mg Taj Pharma Cilostazol Tablets IP 100mg Taj Pharma
Leading Cilostazol Tablets IP 100mg Manufacturers, Suppliers in India
Taj Pharmaceuticals, one of the leading Cilostazol Tablets IP 100mg Manufacturers India brings the best-quality products. The company carries the rich experience in the niche manufacturing of Cilostazol Tablets IP 100mg.
Taj Pharmaceuticals is reputed manufacturer and Cilostazol Tablets IP 100mg suppliers in India prefer Taj Pharmaceuticals due to the reliability and purity of products.
Taj Pharmaceuticals, the well-known Cilostazol Tablets IP 100mg API Manufacturer in India gives the assurance of high-quality and purity. The stringent quality-control ensure that every batch of the drug brings a consistent standard.
As Cilostazol Tablets IP 100mg Exporters, we can cater business queries from the following geographies:
Turkey, Cyprus, Guatemala, El Salvador, Cayman Island, Jamaica, Mozambique, Ecuador, Colombia, Malawi, St Lucia, Papua New Guinea, Gambia, Venezuela, Trinidad & Tobago, Somalia, Guyana, Libya, Seychelles, All West Indies Country, Sierra Leone
When it comes to manufacturing any Cilostazol Tablets IP 100mg, Taj Pharmaceutical always leads. The continuous efforts to become one of the best Cilostazol Tablets IP 100mg manufacturers has made the company to bring the world-class standards – from research laboratories to maintenance. A wide range of life saving Drugs available at Taj Pharma. To manufacture excellent quality Cilostazol Tablets IP 100mg we use high-standard equipment, with the latest technology. Our standard drugs satisfy most of our customers.
Third Party Manufacturer of Cilostazol Tablets IP 100mg
Taj Pharmaceuticals is popular for manufacturing a lot of pharmaceutical and medical products along with Cilostazol Tablets IP 100mg. Taj Pharma is very famous for its competitive price range as well which are nicely suitable for a common man.
Sharing the safest methods and providing the safest product to the customer and client is our first purity and duty as well. Taj Pharma’s keen focus that we provide safety to consume Cilostazol Tablets IP 100mg to our customer along with that we also take care of our workers and all the professionals who are implementing the tasks of manufacturing these injections. Taj Pharmaceuticals has a few manufacturing units and plants in India where all the processes go through under the keen guidance of experts by which create more chances of production of a perfect product with present accuracy. Taj Pharmaceuticals continues its participation in every pharmaceutical event ensures us that we can be able to polish and update our firm. Taj Pharmaceuticals is one of the leading Cilostazol Tablets IP 100mg Manufacturers Suppliers all over India. WHO:GMP Certified Third Party Contract Manufacturing also available.
Contract Manufacturing
Taj Pharmaceuticals is an ISO 9001:2015, WHO:GMP, GLP Certified Pharmaceuticals Company in Mumbai and Gujarat offering more than 1500+ high quality Medical Products. Taj Pharmaceuticals has its own manufacturing unit with sections like Injectable, Tablets, Capsules, Soft Gelatin Capsules, Oral Liquid (Syrup & Suspension), Oral Dry Syrup, External Liquids, Ointments, Creams, Betalactum Products, General Products , Nutraceuticals, Soaps, Shampoo, Eye Drops, Ear Drops , Oral Sachets & Powders , External Powder & Cosmetics. Taj Pharmaceutical has 1500+ product approvals of which many are latest molecules launched in industry. Taj Pharma India caters to all segments like Gynaecology, Dermatology, Ophthalmic, Critical Care, Paediatric, Orthopaedic, Ayurvedic, Nutraceuticals, Cosmetics, Oncology, Cardiac-Diabetic & many more. Third Party Manufacturing & Contract Manufacturing also available.
Manufacturing Unit
Built up area of approx. 100,000 sq. ft with separate areas for production, stores & non process blocks.
Engineering, Utilities to commensurate production facility
Designed and built as per vertical flow concept of man – material movement
Highly skilled and experienced technical staff
Immaculate environmental monitoring, calibration and validation programme
c-GMP compliant with latest manufacturing equipments
Dedicated & modular laboratories with latest sophisticated instruments as per GLP norms
Automated access control system and fully equipped cameras
Separate entry and exit for man, material and service personnel for both process blocks
In house water & sewerage treatment plant.
Online Order Tracking
In order to solve the major problem faced by many pharmaceuticals clients is they are always in a state of dilemma that when their product will be dispatched. They are not able to track the lifecycle of product in a transparent manner which causes loss of trust and commitment. Taj Pharmaceuticals has developed a fully automatic online solution which helps you to immediately determine the production stage of products at any given time. Here are the few stages which you can see:
Design Approved
Carton/ Foil Received
Raw Material Ok & Batch Planned
Batch Processed
Testing Done
Packing Done
Dispatched from Plant
Tracking No.
100% Transparent Process
In order to give you full confidence over the quality of product we provide you with many resources such as:
COA (Certificate of Analysis)
Raw Material Procurement Certificate
Batch Inspection Report
Detailed Test Report across 25+ different parameters
With the sufficient proofs in your hand it becomes easy to convince others about the quality of your products.
New Market Opportunities
We want that our customers should always stay ahead of the competition in market. So in order to make it sure, we provide our customers with valuable market intelligence based on our 30+ years of experience in pharma industry.
Timely updates about new product launches.
Competitor Analysis
Correct MRP Guidance
Promotional Material with training
WHO:GMP Certified
At Taj Pharmaceuticals, we use state-of-the-art technology, the most stringent operating procedures and we have earned a name for ourselves for maintaining the highest standards of quality. Taj Pharma India is proud to have received the WHO:GMP certification from Food and Drugs Control Department, Daman and Gujarat.
Taj Pharmaceuticals provide Medicines of good quality at competitive price from good Manufacturers. Domestic and Export both.
It’s great pleasure to introducing ourselves as one of the leading pharmaceutical company based in Mumbai, Maharashtra and Gujarat, India. Taj Pharmaceuticals Contract Manufacturing Division is marketing partner of some WHO, GMP, GLP, ISO9001-2008 certified manufacturers.
Taj Pharmaceuticals is a leading pharmaceutical Company. We are specialized in providing quality products include complete range of all medicine (Human and Vet) which includes,
Tabs
Dry syrups
Capsules
Dry injections
Liquid Injections
Soft gelatin
Penecilline group
Cefalosporin group
Liquid
Sachets
Ointment/Creams
Neutra products etc.
Some of the salient features of our products are:-
Accurate composition
Effective
Pure
Long shelf life
Our Infrastructure Taj Pharmaceuticals’s manufacturing partners having state-of-the-art infrastructure ensures that all our products are of high quality and adhere to international standards. We have a well-equipped production unit that allows us to meet the ever growing demands of the industry. Taj Pharmaceuticals manufacturing facilities are well-maintained to ensure efficient utilization of resources. Our manufacturing partners have a technologically advanced range of equipment and machinery to facilitate high levels of production.
Our Team Taj Pharmaceuticals have developed a team of experienced professionals that form the backbone of Taj Pharmaceuticals Manufacturing partners, Their dedication and hard work has allowed us to attain a position of respect and repute in the industry. Owing to their efforts and creative approach, we have continuously progressed towards expansion of our business. Their in-depth knowledge and expertise coupled with invaluable guidance of our mentor, ensures competent and efficient execution of our methodologies.
Quality Assurance Taj Pharmaceuticals and its Manufacturing partners aim to become a leading player in global market. To succeed in this endeavour, Taj Pharmaceuticals Manufacturing partners have a nurtured a team of dedicated quality analysts who conduct periodic tests on all production stages from procurement of raw materials till the formulation of final product. Taj Pharma ensure that our unit is hygienically maintained and development & packaging of our products is done under hygienic environment. The parameters on which our products are quality tested are:-
Safety
Composition
Shelf Life
Our Strengths Taj Pharmaceuticals and its Manufacturing partners follows business ethics, zero-tolerance quality policy and a highly qualified team are our strengths. We strive to maintain long lasting relationship with our clients by meeting their requirements effectively and efficiently. The numerous factors contributing to our success are:-
Experienced & Skilled Team
stringent quality checks
Proper infrastructure and machinery
Prompt delivery
Competitive Prices
Wide clientele
Taj Pharmaceuticals is a one stop solution for Export/Domestic 3rd party for all Pharmaceutical Formulations.
Taj Pharmaceuticals is looking forward for your co-operation towards development of concrete business and Hoping for a strong and good business relationship in future.
To know more please do visit our website www.tajpharma.in
Taj Pharmaceuticals manufactures a wide range of pharmaceuticals formulation involving Tablets / Capsules / Injections and Orals. Taj Pharma India team has an excellent expertise in manufacturing and export of Cilostazol Tablets IP 100mg. Taj Pharmaceuticals places its main business as a Pharmaceuticals manufacturing and exports of generic drug supply of Cilostazol Tablets IP 100mg; primarily of pharmaceuticals preparations known as Cilostazol Tablets IP 100mg; as well as more than 100+ generic equivalent drug. Taj Pharmaceuticals has performed these business activities related to exports of Cilostazol Tablets IP 100mg for major foreign-affiliated pharmaceutical import companies, ministry of health, tenders etc. and have enjoyed the full confidence of these companies, instructions and governments.
Taj Pharma Group Under close cooperation between the formulation manufacturing division, active ingredient division and the technology development division for major generic formulations such as Cilostazol Tablets IP 100mg; at Taj Pharma we will appropriately meet diverse needs for Cilostazol Tablets IP 100mg export manufacturing in a wide range of activities from investigation of possible formulations of Cilostazol Tablets IP 100mg, formulation development, making applications to the international regulatory authorities for marketing approval, validation of Cilostazol Tablets IP 100mg through to manufacturing scale production at our cGMP compliant manufacturing units of Taj Pharmaceuticals under the umbrella of Taj Pharma Group.
We at Taj Pharma intend to make our manufacturing systems comply with the requirements of the FDA (cGMP) such that pilot plant scale production of products in the stage of clinical development or for use in clinical studies, as well as manufacture of products in small lots are practicable to ensure a highly stable pharmaceuticals formulations of generic equivalent and bio-similar products. We conduct extensive bio-similar and bio-equivalency studies for all our formations in order to obtain better shelf life, absorption and excellent quality of our generic formulation.
Taj Pharmaceuticals LICENCES & CERTIFICATES for Cilostazol Tablets IP 100mg
WHO-cGMP Certified Taj Pharmaceuticals is manufactures Cilostazol Tablets IP 100mg under WHO-cGMP Plant. Taj Pharma is licenced to manufacture Cilostazol Tablets IP 100mg formulation from Food and Drug Administration of Indian authorities as the rules and regulations with all compliances for international markets.
ISO 9001: 201 All infrastructure of Taj Pharmaceuticals is ISO 9001:201 compliant and Taj Pharma team adheres to the specifies requirements for a quality management system in order to achieve : 1) To demonstrate our ability to consistently provide products and services that meet customer and applicable statutory and regulatory requirements, and. 2) Taj Pharma aims to enhance customer satisfaction through the effective application of the system, including processes for improvement of the system and the assurance of conformity to customer and applicable statutory and regulatory requirements.
All manufacturing units of Taj Pharmaceutical follows the requirements of ISO 9001:201; which are generic under our standard operating procedure (SOP) and we intend such SOPs to be applicable to all manufacturing units, regardless of its type or size, or the products and services we provide.
DUN & BRADSTREET (DUN’S NO.7206112) Taj Pharma is recognised by Dun & Bradstreet; it is a corporation that offers information on commercial credit as well as reports on businesses with Data Universal Numbering System (DUNS numbers.
Third Party / Private Label / Customised Manufacturing
Taj Pharma has excellent infrastructure and drug manufacturing technology to offer private label / third party brands and generics as well; Taj Pharma team invites you to approachus for providing you an option for your products giving your customized requirement from product name to formula; also in international packing and manufacturing standards with all regulatory document needs.
We are exporting our Cilostazol Tablets IP 100mg product in Following Countries:-
Russia and CIS Countries: Azerbaijan, Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Turkmenistan, Uzbekistan and Ukraine
GCC/ Middle East Countries: Saudi Arabia, Yemen, Oman, Bahrain, UAE, Lebanon, Jordan, Iraq.
Southeast Asia: Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, Vietnam, Brunei Darussalam
Other Asian Countries: Nepal, Myanmar, Malaysia, Cambodia, Bhutan, Sri Lanka, Mauritius
Cilostazol Tablets IP 100mg Regulatory Documents:
Certificate of Analysis (COA)
Method of Analysis (MOA)
Stability Data (Accelerated stability / Long term stability / Zone 4b)
CTD Dossier / ACTD Dossiers / eCTD Dossiers
Certificate of Pharmaceuticals Product (COPP)
Free Sale Certificate (FSC)
Want to get your products Manufactured by Taj Pharma?
We at Taj Pharmaceuticals would be happy to help you. Just send your details below and we will take care of everything. (Please don’t post job queries here)
Taj Pharma As A Health Care Provider We put the customer at the front of every decision we make.
Taj Pharma India’s business can be contacted by common group e-mail: tajgroup@tajpharma.com, and query — will be forwarded to the relevant departments; additionally, telephone lines, ” Please Call TAJ PHARMA’s 24X7 helpline number i.e. 1800 222 434 (toll-free), 1800 222 825 (toll-free) Toll free numbers are accessible from all landlines and mobile phones in the country.” can be utilised if -you have an enquiry about the company, our healthcare business, or one of our medicines at India Standard Time (IST).
Dexamethasone is a type of corticosteroid medication manufactured by Taj Pharmaceuticals India. It is used in the treatment of many conditions, including COVID-19 respiratory side effects, rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling, eye pain following eye surgery, and along with antibiotics in tuberculosis. In adrenocortical insufficiency, it should be used together with a medication that has greater mineralocorticoid effects such as fludrocortisone. In preterm labor, it may be used to improve outcomes in the baby. It may be taken by mouth, as an injection into a muscle, or intravenously. The effects of dexamethasone are frequently seen within a day and last for about three days.
Oman, the historic and strategically positioned nation at the confluence of the Gulf and the Arabian Peninsula, boasts a vibrant pharmaceutical industry that has been thriving in recent years. In this comprehensive article, we will delve into the captivating history, key players, and promising future prospects of the pharmaceutical landscape in Oman. Oman’s Historical Tapestry Taj Pharmaceuticals in Oman Oman’s historical narrative is nothing short of captivating. From the 17th century onwards, the Omani Sultanate emerged as a formidable empire, vying for influence with the Portuguese and British empires in the Persian Gulf and the Indian Ocean. By the 19th century, Oman’s reach extended across the Strait of Hormuz to Iran and Pakistan, and down the East African coast to Zanzibar. A pivotal moment in Oman’s history came in 1970 when Sultan Qaboos took the reins of power. He initiated a comprehensive modernization program, abolishing slavery, which had once been a significant part of the country’s trade. However, challenges loomed, notably the 1965-75 Dhofar Rebellion. Pro-Soviet secessionist forces posed a threat to Oman’s territorial integrity, but with military support from the UK, Iran, Jordan, and Pakistan, the rebellion was quelled. While Oman may have weathered the storm of political dissent […]
Taj Covi Safe Kit Contains Zinc Acetate 50 mg, Doxycycline 100 mg & Ivermectin 12 mg Dispersible Tablets. Taj Covi Safe Kit is currently indicated in the first line treatment for COVID-19 positive patients.
The medical research community is collaborating in unprecedented ways, and working overtime, to fight COVID-19. Academics, public health agencies, biotech, and big pharma are working together to repurpose existing drugs, develop new therapies and protect us with new vaccines. What can we expect them to deliver — and when?
Last week, the Centers for Disease Control and Prevention issued new face-mask guidance, encouraging everyone to wear cloth face coverings when in public. The reasoning: “We now know from recent studies that a significant portion of individuals with coronavirus lack symptoms,” and that those individuals can transmit the virus to others. Covid-19 hotspot, Coronavirus Live, Covid-19 state-wise Cases, Coronavirus cases in India, Dharavi Covid-19 cases, Covid-19 Cases, Covid-19, Covid-19 Lockdown, Covid-19 update
The WHO said there’s no evidence serological tests can show whether a person has immunity or is no longer at risk of becoming reinfected. The World Health Organization issued a warning Friday about coronavirus testing, saying there’s no evidence serological tests can show whether a person has immunity or is no longer at risk of becoming reinfected.
Developing a Vaccine with New Technology Around 10 January, Chinese scientists developed and shared a full genetic sequence of SARS-Cov2, the virus that causes COVID-19, colloquially called coronavirus. Several companies are using this information to develop vaccines that will contain a small amount of genetic code. Certain cells in the body will take up this genetic information and produce elements of the virus, not infecting the person but triggering the immune system to respond. DNA or RNA based vaccines are not made with a weakened or deactivated virus, nor elements of the virus, so they can be produced in the lab. This approach is faster and more reliable than traditional vaccine processing, which uses virus grown in eggs or cell cultures. For example, Moderna, in collaboration with the National Institute of Allergy and Infectious Disease (USA), developed the first COVID-19 vaccine in clinical trials using a genetic platform called messenger RNA (mRNA). It took only 42 days to move from vaccine design to human testing – an industry record. While genetic platforms are promising and fast, there are currently no such vaccines approved for human use. In addition to the many companies pursuing vaccines on this platform, other companies are […]
Research has emerged suggesting coronavirus survivors’ plasma could save lives; Scientists are in disagreement over whether the virus is airborne or not; A study also suggests that cats can contract the virus and transmit it to other cats.
We need to find out who has the antibodies to the virus. Testing to see who has the Covid-19 coronavirus has become one of the most crucial elements of slowing the global pandemic. And it may also hold the key to a return to normal.
“The infection enigma,” explained. In the worst cases of Covid-19, the virus not only attacks and destroys tissue in the lungs but also triggers an overreaction of the immune system, creating dangerous levels of inflammation. Many of these patients are left unable to breathe on their own, and some die in hospital intensive care units, or at home.
Warming catalyses antimicrobial resistance Warmer climatic conditions are giving rise to infectious diseases like malaria, dengue, gastroenteritis, wound infections, septicaemia and cholera, caused by Vibrio bacteria, warned the Lancet Countdown Report 2019 on Health and Climate Change. The annual update was on 42 indicators across five topics: Climate change impacts, exposures, and vulnerabilityAdaptation, planning, and resilience for healthMitigation actions and health co-benefitsEconomics and financePublic and political engagement The report identified the prevalence of infectious diseases due to climate change among the climate change indicators. As an example of how warmer conditions affect health, it cited how the number of days for the Vibrio bacteria to reproduce and spread has doubled since 1980. Also, increased sea-surface temperature increased the risk of Vibrio cholerae infections, Rachael Davies, communications consultant with Lancet told Down To Earth. The climactic conditions also favoured the quick spreading of other pathogens, Davies added. The report released November 13, 2019, warned that 2018 was second on record for suitable conditions for the transmission of diarrhoeal disease and wound infections from Vibrio (since 2000). Children were more susceptible to diseases such as diarrhoea and dengue. Warmer climate also acted as a catalyst in spreading antimicrobial-resistance (AMR). It has already emerged in […]
What to do if you suspect you might have Covid-19. COVID-19 is a rapidly spreading disease, caused by a coronavirus that jumped from animals to humans in late 2019. Here are the most pressing and recent questions related to the fast-moving pandemic. Coronavirus: What are the symptoms of Covid-19? How to seek medical advice, explained
What You Should Know US authorities have given the green light to a new COVID-19 booster shot designed to combat one of the most prevalent strains of the virus currently in circulation. As we approach the cold and flu season, the Food and Drug Administration (FDA) has granted emergency use authorization for updated single-dose COVID-19 booster shots. The Centers for Disease Control and Prevention (CDC) panel of experts has also recommended that nearly all US residents consider getting this booster. In this article, we will provide you with essential information about these new booster shots, including who should get them and why. What Did the FDA Approve? The FDA has authorized updated versions of the Pfizer and Moderna mRNA vaccines. COVID-19, like the influenza virus, continually mutates. To address this, pharmaceutical companies have developed a booster shot targeting one of the most widespread strains of COVID-19 this season, known as the XBB.1.5 variant. This fall marks the first time that adults will have access to vaccines protecting against the flu, respiratory syncytial virus (RSV), and COVID-19, all of which safeguard against commonly circulating respiratory illnesses. This year’s COVID-19 booster specifically targets the XBB.1.5 variant. Who Should Receive the New Booster […]
In mid-March, when the reality of Covid-19 was setting in across the United States, alcohol sales soared. According to figures quoted by Bloomberg News, beer and wine sales surged 32% and 47%, respectively. Sales of hard liquor and cocktail mixes rose even more. Facing the prospect of extended stay-at-home restrictions, it seems that many Americans were in a hurry to stock their home bars and liquor cabinets.
Tablets are one of the most commonly used solid dosage forms. These tablets are carefully crafted by compressing or molding a powdered drug into a specific shape and size. This process, known as formulation development, is a critical stage in pharmaceutical manufacturing. In this article, we will explore the fascinating world of Taj Pharmaceuticals Limited and their role in this intricate process. Understanding Tablets and Formulation Development Tablets are not just pills; they are the result of a complex formulation process. This process involves selecting appropriate excipients, binders, disintegrants, and other additives to ensure the tablet’s integrity and its ability to dissolve effectively in the body. It’s akin to creating a precise recipe, where each ingredient plays a vital role in the final product. The Pillars of Formulation Excipients: These are inactive substances that serve as the vehicle for the active drug. They play a crucial role in ensuring that the drug is delivered effectively to the body. Binders: Binders are like the glue that holds the tablet together. They provide the necessary cohesiveness to the mixture. Disintegrants: These components facilitate the tablet’s breakdown once it’s ingested, ensuring that the active drug is released and absorbed efficiently. Additives: Various additives, […]
The FDA has approved an abbreviated new drug application for hydroxychloroquine sulfate tablets to address ongoing shortages of the drug sparked by its still unproven potential as a COVID-19 treatment.
Meta-analysis finds some ivermectin benefits in COVID-19 patient An analysis published in Open Forum Infectious Diseases found a 56% reduced risk of mortality for COVID-19 patients taking the anti-parasitic drug ivermectin compared to standard of care or another therapy. The study pulled data from 24 randomized trials involving 3,328 patients with moderate to severe COVID-19. Ivermectin tablets USP 12 mg (Iverotaj 12) The study also found that ivermectin was “associated with reduced inflammatory markers” and quicker viral clearance. Ivermectin, a widely available inexpensive drug used to treat worm and scabies infections in humans and animals, has emerged as a COVID-19 treatment in several parts of the world. Its use, however, has been controversial. WHO has counseled against its use as a COVID-19 treatment outside of clinical trials. And Merck, an ivermectin manufacturer, released a statement in February saying there was no scientific evidence to support the use of ivermectin for COVID-19. A study recently published in the American Journal of Therapeutics also found some benefits for ivermectin in treating COVID-19 with moderate-certainty evidence. The data from the study published in Open Forum Infectious Diseases is unlikely to convince skeptics. Nine of the studies involved in the meta-analysis were preprints. Another […]
Ivermectin led to a 100% reduction in hospitalisation rate, a 92% reduction in mortality rate and an 86% reduction in the risk of dying from a COVID-19 infection BY WILL JONES 3 SEPTEMBER 2022 5:55 PM Regular use of ivermectin led to a 100% reduction in hospitalisation rate, a 92% reduction in mortality rate and an 86% reduction in the risk of dying from a COVID-19 infection when compared to non-users, a major new study has found. Ivermectin Tablets USP 12 mg (Iverotaj 12) The study, published in the medical journal Cureus, analysed data from 223,128 people from the city of Itajaí in Brazil and is the largest study of its kind, giving its findings a high degree of certainty. Senior author Dr. Flavio A. Cadegiani wrote on Twitter: “An observational study with the size and level of analysis as ours is hardly achieved and infeasible to be conducted as a randomised clinical trial. Conclusions are hard to be refuted. Data is data, regardless of your beliefs.” The study compared those who took ivermectin regularly, irregularly and not at all prior to being infected with COVID-19 (i.e., as prophylaxis), and found a dose-dependent relationship, confirming that the difference in outcomes is very likely to be due […]
Pharmaceutical firm Taj Pharma has announced that it has introduced Covid-19 treatment drug Molnupiravir under brand name “Molnutaj” in India. Molnupiravir is for treatment of adult patients hospitalised with COVID-19, under certain conditions, drug maker said.
{Taj Pharmaceuticals} Stomach cancer symptoms, diagnosis and treatment: STOMACH cancer is one of the most common types of cancer and one of the top causes of cancer deaths worldwide. Survival rates for the deadly disease stand at just 14 percent. With these worrying statistics its imperative for one to spot the early signs of stomach cancer, and feeling a certain burning sensation could mean you’re at risk. Stomach cancer is characterised by a growth of cancerous cells within the lining of the stomach. Also known as gastric cancer, it’s a type of cancer that is difficult to diagnose. The National Cancer Institute (NCI) estimates there’ll be approximately 28,000 new cases of stomach cancer in 2017. Since stomach cancer usually doesn’t cause any early symptoms, it often goes undiagnosed until after it spreads to other parts of the body. Feeling an acid reflux that persists and a burning sensation could signal the deadly disease. Stomach cancer is directly linked to tumours in the stomach. Risk factors for the disease include a group of blood cancers, a common stomach infection that can sometimes lead to ulcers, tumours in other parts of the digestive system or abnormal growths of tissue that form on […]
It might be difficult to implement compulsory prescription of generics The enforcement by the drug regulator will not be easy given the shortage of drug inspectors – {Taj Pharmaceuticals Generic Drug Division} Prime Minister Narendra Modi wants to defeat the doctor-pharmaceutical company nexus and make medicines affordable by making it compulsory to prescribe drugs in the generic name. But, the good intentions may not give the desired results. The enforcement will not be easy given the shortage of drug inspectors. At an industry event at Surat last month, Modi announced plans for a new law to make generic prescriptions mandatory. Parallelly the government is already initiating steps to push for generic prescriptions. In a recent communication to all the states, the Centre has asked states to make sure all physicians write generic names of drugs in a legible manner. Business Standard has reviewed the letter. The government has issued a draft amendment which will make it mandatory for companies to print generic names of the drug in a bolder font than the brand name on the packaging. But, the government will face a difficult task in enforcing its decisions. Food and Drug Administration offices across the country are short staffed. […]
Scientists say a moonshot effort is needed to end social distancing and this pandemic. Will leaders listen? The failures of the United States’ initial response to the Covid-19 pandemic are already well established: Officials were too slow to recognize the threat of the disease and too slow to get diagnostic testing in place, and were ill prepared for the strain on our health care system.
New Covid variant Eris symptoms appear a week before positive test? Know all about this ‘pre-Covid’ phenomenon In the ever-evolving landscape of the COVID-19 pandemic, new variants continue to emerge, each with its own set of characteristics and challenges. Among the latest variants to capture attention is the Eris variant, specifically EG.5. This variant has been spreading rapidly in various parts of the world, raising concerns and questions about its symptoms and detection. Understanding the Eris Variant EG.5, a sub-variant of the coronavirus, has garnered attention for its ability to spread quickly. However, experts have noted that the symptoms associated with this variant are relatively mild, and it doesn’t pose a significant threat in terms of severity. Despite this, EG.5 has been declared a variant of interest, and health authorities are closely monitoring its mutations. It’s worth noting that the rapid spread of EG.5 has led to some intriguing observations in the form of a ‘pre-Covid’ phenomenon. The ‘Pre-Covid’ Phenomenon What is the ‘pre-Covid’ phenomenon, and why are people reporting it in connection with EG.5 and other Omicron variants? To understand this, we need to delve into the incubation period of the virus. When a person contracts a virus like […]
India reported the first confirmed case of the coronavirus infection on 30 January 2020 in the state of Kerala. The affected had a travel history from Wuhan, China.
Masks, and other much needed medical equipment, are in short supply all across the world.Ventilators for patients with severe cases of COVID-19 are in short supply globally. The new coronavirus has infected more than half a million people worldwide. Companies including Dyson and Ford Motor Company are stepping up to meet the demand for ventilators, alongside other innovations.
Most people have little control over when or whether they can — or have to — go back to work, as health officials, politicians, and companies make decisions about restarting the economy. But there are several steps many workers can take, particularly office workers, to reduce the risk of infection for themselves and co-workers when they do go back. These measures dovetail with preventive steps bosses and business owners can take in order to avoid fresh outbreaks and keep their workers safe.
What the experts say? A daily Covid-19 update from Taj Pharmaceuticals Limited Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
A daily Covid-19 update from Taj Pharmaceuticals Limited Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
Symptoms of the novel coronavirus can vary a lot, if an infected person experiences them at all. What are the signs you have been infected with the Covid-19 coronavirus? That’s become a surprisingly tricky question to answer, and it’s hampering the fight against the disease.
Local data simply isn’t available, while state and national totals woefully underreport the reality. A daily Covid-19 update from Taj Pharmaceuticals Limited Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
In recent years, the world has witnessed the devastating impact of the COVID-19 pandemic, which originated in Wuhan, China. While the origins of the virus have been a subject of debate and investigation, one prominent virologist, Chinese scientist Shi Zhengli, often referred to as “Batwoman” due to her extensive research on viruses originating from animals, has issued a sobering warning. According to a report by the South China Morning Post, Shi Zhengli and her colleagues at the Wuhan Institute of Virology have evaluated various coronavirus species, raising concerns about the potential emergence of another COVID-19-like virus in the future. Understanding the Threat China’s ‘Batwoman’ Virologist Coronaviruses are not new to the world of infectious diseases. They have previously sparked significant outbreaks, including the 2003 Severe Acute Respiratory Syndrome (SARS) and the ongoing COVID-19 pandemic that began in 2019. Shi Zhengli’s research has delved into 40 different coronavirus species, assessing their potential to spill over into human populations. Alarming Findings Shi Zhengli’s findings are indeed alarming. Her research has identified six types of viruses, half of which have previously caused deadly diseases in humans, categorized as high-risk. The remaining three have infected other animal species. This leads to a troubling prediction: […]
Management of mild to moderate COVID-19 during the wave in India; Doctor Believes Ivermectin Drug Can Help With COVID-19 taking a tight grasp on the lives of people in India and around the world, experts have been tirelessly searching for existing medications that can help combat this relentless virus. While vaccines like Pfizer, Moderna, and AstraZeneca have been pivotal in the fight against COVID-19, there’s a growing interest in repurposing drugs. Among them, one that has gained significant attention is Ivermectin. In this comprehensive article, we delve into the potential of Ivermectin in managing mild to moderate COVID-19 cases, its history, and its current status in India. Ivermectin: The Wonder Drug? Ivermectin Tablets USP 12 mg (Iverotaj 12) Ivermectin, an anti-parasitic drug, has a storied history. It has proven beneficial in treating various tropical diseases, including onchocerciasis, helminthiases, and scabies. However, its origins lie in veterinary medicine. In the 1960s, Satoshi Omura, a microbiologist at Tokyo’s Kitasako Institute, and William Campbell from New Jersey discovered that a culture of bacteria known as Streptomyces avermictilis was effective against worms. They later chemically modified its active component, avermectin, making it safer and more effective. This led to the birth of Ivermectin, which […]
Remdesivir is considered as a key antiviral drug in the fight against COVID-19, especially in adult patients with severe complications The direction comes against reports of global shortages of the critical drug. Remdesivir is considered as a key antiviral drug in the fight against COVID-19, especially in adult patients with severe complications. The new wave came as a surprise after production was not continued as many countries were more focused on vaccination. The countries such as Venezuela has decided to procure remdesivir injections from Indian firms who can export, so that they could be provided treatment of critical COVID-19 patients from the economically weaker sections.
As the novel coronavirus (COVID-19) situation continues to evolve and business impacts are becoming more far reaching across every sector, I wanted to share what we are doing at Taj Pharmaceuticals to ensure the continuity in our support of you and the people in your care. Read more
‘A combination of approved Ivermectin, Zinc and Doxycycline has shown positive results for COVID-19 and should be considered immediately to fight the pandemic’ Taj Covi Safe Kit Contains Zinc Acetate 50 mg, Doxycycline 100 mg & Ivermectin 12 mg Dispersible Tablets Australia’s The Centre for Digestive Disease (CDD) Medical Director Professor Thomas Borody MB, BS, BSc(Med), MD, PhD, DSc, FRACP,FACP,FACG, AGAF, says FDA and TGA approved Ivermectin which he uses regularly in his hospital, has shown positive results for COVID-19 and should be considered immediately to fight the pandemic. Ivermectin was discovered in the 1970s and is on the World Health Organization (WHO) list of essential medicines. Professor Borody has used the same methodology with the COVID-19 Ivermectin Triple Therapy as he used when he developed the world’s first cure for peptic ulcers saving millions of lives around the globe. He says this combination of 3 approved “off the shelf” drugs could be the answer to Australia’s COVID-19 crisis. “If nothing else, make it available in aged care homes immediately. Our elderly are at the highest risk and this is a very safe option especially when we have nothing else except ventilators. Also, our frontline workers deserve more protection with a preventative […]
‘No one has a real idea of what the total demand is likely to be before the epidemic ends’ “Close the borders! Ground the planes!” Such responses are natural and understandable, but, taken too far, may become counterproductive. Social distancing for individuals is an unfortunate necessity; for countries, the reflex threatens to turn into a terrible policy. The same hoarding impulse to take care of your own, which has led to unnecessarily empty toilet paper shelves all over the world, may exacerbate a far more serious shortage: getting ventilators to the people who need them.
Clinical trials will test if antibodies against the coronavirus prevent infection, aid survival. A patient in Beijing who has recovered from COVID-19 donates plasma, the liquid part of blood, which contains antibodies against the coronavirus.
The latest on the potential Covid-19 treatment under research. A daily Covid-19 update from {Taj Pharmaceuticals Limited} Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
We Taj Pharmaceuticals are in the midst of challenging times, brought upon us due to the unimaginable spread of COVID-19. As we grapple with this difficult and ever evolving situation, we wanted to reach out to make sure that you are doing okay and in case you needed any help. It is hard to think of a business that is not impacted by this pandemic, the effects of which we will all continue to feel for a long time. Considering the current situation across the globe wherein everyone is trying their best to tackle the Coronavirus pandemic, we understand that we aren’t insulated from any uncertainties too. We, as an organisation, are doing our bit to ensure the safety and security of our employees, partners, etc. while ensuring that the work isn’t hampered. coronavirus As a firm, we have always placed the highest emphasis on delivering quality generics to all our clients, consistently. I want to take this opportunity to assure you that our professional commitments continue to occupy an important place for all of us at Taj Pharmaceuticals even as we steer our way through the crisis. Our Values of Care and Working Together come to fore in difficult […]
{Taj Pharmaceuticals} Finding a cure for hepatitis B: The NIH announced a plan to “intensify” ongoing hepatitis B virus research that is focused on finding a cure and improving screening and treatment for the infection. For nearly 40 years, there has been an effective vaccine to prevent HBV, but the virus still causes an increasing number of illnesses and deaths worldwide each year. Focusing on three critical research areas, the Strategic Plan for Trans-NIH Research to Cure Hepatitis B aims to address the global public health challenge that HBV presents. Healio spoke with National Institute of Allergy and Infectious Diseases Director Anthony S. Fauci, MD, about the plan, the “crucial” role that clinicians play, and how close the world is to a cure for HBV. – by Marley Ghizzone Q: What was the impetus for the plan? A: Hepatitis B is a prevalent and serious disease. The global disease burden is approximately 257 million chronic infections worldwide — 850,000 to 2.2 million in the United States — and approximately 900,000 deaths per year, with those numbers increasing. There are new scientific opportunities to pursue due to the identification of a cell receptor for HBV, more advanced cell culture systems and […]
The NHS has embarked on an urgent mission to administer booster shots of Covid and flu vaccines to older residents in care homes across England. This accelerated rollout, set to commence on Monday, aims to swiftly bolster the immunity of those who are at the highest risk due to the emergence of a highly-mutated new Covid variant known as BA.2.86. The BA.2.86 Variant Emergence As of now, there have been 34 confirmed cases of the BA.2.86 variant in England, with a concerning outbreak reported in a care home in Norfolk, accounting for 28 of these cases. Although it’s too early to determine the severity of this new variant compared to its predecessors, the rapid spread has raised alarm bells within the medical community. Prioritizing High-Risk Groups The rollout will initially target adult care homes and housebound individuals, gradually expanding to encompass other eligible groups. Scotland, Wales, and Northern Ireland have also expedited their booster vaccination schedules, beginning in early September. Eligibility for Covid Booster People eligible for the Covid booster include: Residents in care homes for older adults. All adults aged 65 years and over. Individuals aged six months to 64 years in clinical risk groups. Frontline health and social […]
Taj Pharmaceuticals Biotechnological Division has announced the research in order to create an mRNA vaccine against SARS-COV-2 (coronavirus). Development will be based on previous pipelines for mRNA-oncovaccines creation: an area where the company has a great expertise. The first animal studies are scheduled for the end of April.
Fun fact: Radish greens make greatpesto. Toss them in the blender with some oil and garlic and whatever nuts and/or cheese you can scrounge up and you’ve got yourself a killer sauce. #CoronaVirus #CoronaPrevention #Safety #tajpharmaCorona #CoronaSpread #IndiaFightsCorona #CoronavirusOutbreakindia #CoronavirusPandemic #StaySafeStayHome #IndiaFightsCoronavirus
How the coronavirus travels through the air has become one of the most divisive debates in this pandemic. A daily Covid-19 update from Taj Pharmaceuticals Limited Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
Even as hospitals and governors raise the alarm about a shortage of ventilators, some critical care physicians are questioning the widespread use of the breathing machines for Covid-19 patients, saying that large numbers of patients could instead be treated with less intensive respiratory support. A daily Covid-19 update from Taj Pharmaceuticals Limited Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
A new peer-reviewed study by Dr Pierre Kory and colleagues on Ivermectin has been published in the American Journal of Therapeutics. Entitled “Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19“, it provides a new authoritative overview of the evidence to date and calls for the widely available drug to be “globally and systematically deployed in the prevention and treatment of COVID-19”. The study summarises the impressive evidence base for the use of Ivermectin. Ivermectin dispersible tablets 12mg Iverotaj D.T. 12 1. Since 2012, multiple in vitro studies have demonstrated that Ivermectin inhibits the replication of many viruses, including influenza, Zika, Dengue, and others.2. Ivermectin inhibits SARS-CoV-2 replication and binding to host tissue through several observed and proposed mechanisms.3. Ivermectin has potent anti-inflammatory properties with in vitro data demonstrating profound inhibition of both cytokine production and transcription of nuclear factor-κB (NF-κB), the most potent mediator of inflammation.4. Ivermectin significantly diminishes viral load and protects against organ damage in multiple animal models when infected with SARS-CoV-2 or similar coronaviruses.5. Ivermectin prevents transmission and development of COVID-19 disease in those exposed to infected patients.6. Ivermectin hastens recovery and prevents deterioration in patients with mild to […]
It’s complicated … most vaccines used today took between 5-15 years to perfect. Time to get a COVID-19 vaccine to market is likely to be at least 18 months.Potential treatments require testing and funding.International organizations are helping to fund research. COVID-19 is new and scientists understand little about how it behaves and spreads. The cost of creating a vaccine to protect people against the new coronavirus will run into billions of dollars and could take many months. Here are some of the reasons why. COVID-19 Vaccines are complex to make Technology is enabling new methods of exploring vaccine candidates for trial, but there are already a few tried and tested ways to make them. In all of them, scientists try to stimulate the body’s immune system to combat invasive pathogens. That’s commonly done by creating something so similar to the pathogen that the body begins to create antibodies to fight off the real thing. The most common way of doing this is to make what’s called attenuated vaccines – those that are made of weaker strains of the actual pathogen. Reared on animal cells outside of human bodies (some flu vaccines are cultured on chicken eggs), they are then extracted […]
Although several clinical trials are now underway to test possible therapies, the worldwide response to the COVID-19 outbreak has been largely limited to monitoring/containment. We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addition to Vero-hSLAM cells 2 h post infection with SARS-CoV-2 able to effect ~5000-fold reduction in viral RNA at 48 h. Ivermectin therefore warrants further investigation for possible benefits in humans. Ivermectin Tablets USP 12 mg (Iverotaj 12) Source: https://doi.org/10.1016/j.antiviral.2020.104787 1. Introduction Ivermectin is an FDA-approved broad spectrum anti-parasitic agent (Gonzalez Canga et al., 2008) that in recent years we, along with other groups, have shown to have anti-viral activity against a broad range of viruses (Gotz et al., 2016; Lundberg et al., 2013; Tay et al., 2013; Wagstaff et al., 2012) in vitro. Originally identified as an inhibitor of interaction between the human immunodeficiency virus-1 (HIV-1) integrase protein (IN) and the importin (IMP) α/β1 heterodimer responsible for IN nuclear import (Wagstaff et al., 2011), Ivermectin has since been confirmed to inhibit IN nuclear import and HIV-1 replication (Wagstaff et al., 2012). Other actions of ivermectin have been reported (Mastrangelo […]
Full disclosure, I spend about 73% of my time obsessing about whether there will be summer camp in Rhode Island. I send borderline appropriate emails to people I work with on virus response, nagging them about this. CoronaVirus #CoronaPrevention #Safety #tajpharmaCorona #CoronaSpread #IndiaFightsCorona #CoronavirusOutbreakindia #CoronavirusPandemic #StaySafeStayHome #IndiaFightsCoronavirus
— Drug to be given to comatose Illinois patient after docs refusedby Jennifer Henderson, Enterprise & Investigative Writer, MedPage Today May 4, 2021 Ivermectin Tablets USP 12 mg (Iverotaj 12) An Illinois judge has ordered a hospital to give ivermectin to a comatose patient with few options left. Judge James Orel of DuPage County ordered Edward-Elmhurst Hospital to allow 68-year-old COVID-19 patient Nurije Fype to receive the drug, even though it isn’t endorsed by federal health agencies, the Chicago Tribune reported. Fox 32 Chicago reported that Fype, who has been in the intensive care unit since early last month and is currently on a ventilator, has since received her first dose. Her daughter, Desareta Fype, enlisted the help of a New York law firm that has taken on other ivermectin cases to force the hospital’s hand after none of its doctors would agree to administer the drug, according to the local media outlets. The Tribune reported Tuesday that an outside doctor was granted credentials at the hospital to administer the ivermectin. “‘Why wouldn’t this be tried if she’s not improving?’” the Tribune quoted Judge Orel as saying during a court hearing. “‘Why does the hospital object to providing this medication? […]
China coronavirus: All you need to know – A new virus has killed 81 people in China and infected almost 3,000 people, with cases confirmed in several countries. Coronavirus: Everything you need to know Health authorities around the world are grappling with an outbreak of a new coronavirus, which originated in the Chinese city of Wuhan. At least 81 people have died in China and almost 3,000 have been infected worldwide. What is a coronavirus? Coronaviruses are a large family of viruses that cause illnesses ranging from the common cold to more severe diseases such as Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS), according to the World Health Organization (WHO). They circulate in animals and some can be transmitted between animals and humans. Several known coronaviruses are circulating in animals that have not yet infected humans. The new coronavirus has been named novel coronavirus (2019-nCoV). It is the seventh coronavirus known to affect humans. What are the symptoms? Common signs of infection include fever, coughing and breathing difficulties. In more severe cases, infection can cause pneumonia, SARS, kidney failure and death. The incubation period of the new coronavirus is thought to be between one and 14 […]
The test can run on small machines the size of a toaster; A daily Covid-19 update from Taj Pharmaceuticals Limited Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
Covid-19’s duration varies widely depending on severity, but now we know the rough range. In the early weeks of the Covid-19 crisis, little was known about the wide range of possible symptoms and the typical progression of the disease. Now, more than three months into the coronavirus outbreaks, doctors and researchers are finally getting a handle on the typical duration of the illness and how it plays out.
Taj Pharma India | Taj Pharmaceuticals India | Taj Pharma | Taj Pharma Hyderabad | Taj Pharma Mumbai | Taj Pharma Bombay | Taj Pharma News | Taj Pharma India News | Taj Pharma Updates | Taj Pharma Products | Taj Pharmaceuticals Products | Taj Pharma Owner | Taj Pharma CEO | Taj Pharmaceuticals CEO | Taj Pharma Jobs | Taj Pharma Vacancy | Taj Pharma Review | Taj Pharma Director
{Taj Pharmaceuticals Ltd} [Latest generic drug news] What’s the difference between a cold and the flu The common cold and the flu may seem similar at first. They’re both respiratory illnesses and can cause similar symptoms. But different viruses cause these two conditions. Your symptoms help you tell the difference between them. Both a cold and the flu share a few common symptoms. People with either illness often experience: As a rule, flu symptoms are more severe than cold symptoms. Another distinct difference between the two is how serious they are. Colds rarely cause other health conditions or problems. But the flu can lead to sinus and ear infections, pneumonia, and sepsis. To determine whether your symptoms are from a cold or from the flu, you need to see your doctor. Your doctor will run tests that can help determine what’s behind your symptoms. If your doctor diagnoses a cold, you’ll only need to treat your symptoms until the virus has run its course. These treatments can include using over-the-counter (OTC) cold medications, staying hydrated, and getting plenty of rest. Taking flu medicine early in the virus’ cycle may help reduce severity of illness and shorten the time that you […]
COVID-19 Taj Pharma CEO Generics Supply COVID-19 trials COVID-19 treatments Generics Supply Centers COVID-19 clinical trials coronavirus ongoing trials Coronavirus Cases in India breaking news updates on Coronavirus in India Coronavirus updates Latest Coronavirus News Coronavirus new cases outbreak of coronavirus disease (COVID-19)
We have entered an age of social distancing. As we know, living as we do now slows the rise of the Covid-19 pandemic by reducing the number of interactions people have in a day, limiting the virus’ capacity to spread. #CoronaVirus #CoronaPrevention #Safety #tajpharmaCorona #CoronaSpread #IndiaFightsCorona #CoronavirusOutbreakindia #CoronavirusPandemic #StaySafeStayHome #IndiaFightsCoronavirus
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Coronavirus FAQs Coronavirus in India: how the 2019-nCoV could impact the world’s second–most populated country Coronavirus-affected countries: Italy Middle East South Korea Japan Singapore Malaysia China USA UK Thailand Philippines Latest on India coronavirus (Covid-19) situation, followed by details on states, union territories and cities. For latest coronavirus news updates, jump to NCR, Punjab, Tamil Nadu, Haryana, Telangana, Rajasthan, Uttar Pradesh, Karnataka, Bihar, Ladakh, Jammu and Kashmir, Andhra Pradesh, Maharashtra, Odisha, Himachal Pradesh, Mizoram, Kerala.
India is home to highest number of drug-resistant TB patients Administering anti-malarial drug Chloroquine (CQ) with anti-TB drugs can reduce the tolerance of the TB bacteria, mycobacterium tuberculosis (Mtb), towards it. That, in turn, can help fight drug-resistant TB, according to a new research whose findings were published in Science Translational Medicine, a journal of American Association for the Advancement of Science. The first-of-its-kind research was conducted on mice by scientists from the Indian Institute of Science in collaboration with the National Centre for Biological Science and Foundation for Neglected Disease Research. If it translates into positive results for clinical trials on humans, it will be an important milestone for India. The country has the most number of TB and drug-resistant TB cases, according to the Global TB report 2019. India contributed to as many as 27 per cent of the world’s drug-resistant TB cases, followed by China (14 per cent). That means India harbours 130,000 drug-resistant TB cases. A challenge in TB treatment is that it takes six months or more as the bacteria persists in the body for long and strongly fights the drug. The drug thus takes long to kill the bacteria. The duration gives the bacteria enough time […]
WHO officially names new coronavirus disease Covid-19 The World Health Organization (WHO) has officially named the disease caused by the new coronavirus, initially identified in Wuhan, China, as Covid-19.
In the news today: the world passed 1 million cases of Coronavirus. A daily Covid-19 update from Taj Pharmaceuticals Limited Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
Here’s the timeline of how the Coronavirus outbreak evolved from Wuhan city in China and spreading its tentacles across the world. Update: DBS evacuates 300 after one is infected – Singapore’s DBS bank has evacuated 300 employees after one employee was confirmed to have contracted the coronavirus. Japan cruise cases increase to 174 – The total confirmed cases on the Diamond Princess cruise ship, quarantined in Japan, have surged to 174. Death toll reaches 1,115; recoveries rise – Deaths from the new coronavirus have reached 1,115, while the total number of cases exceeded 45,100, including 44,653 reported in mainland China by authorities as of the end of 11 February. – According to NHC official Mi Feng, the proportion of recovered patients in China increased to 8.2% as of 10 February, from 1.3% on 27 January. WHO gives name to new coronavirus disease – The WHO has officially named the disease caused by the new coronavirus as ‘Covid-19’. – Ukraine is screening five of its citizens for the novel coronavirus, Health Minister Zoriana Skaletska said at a press briefing on 11 February. – According to Skaletska, three of the five suspected patients returned from China while the remaining two were in […]
Choirs are a secret lifeblood of our country. It’s unclear when and how we’ll ever sing together again. #CoronaVirus #CoronaPrevention #Safety #tajpharmaCorona #CoronaSpread #IndiaFightsCorona #CoronavirusOutbreakindia #CoronavirusPandemic #StaySafeStayHome #IndiaFightsCoronavirus
More than 350,000 people have tested positive for the COVID-19 novel coronavirus around the world, with confirmed positives surging as testing becomes more widespread. More than 15,000 people have died due to complications from the virus.
Taj Pharmaceuticals, one of the leading COVID -19 medicines Manufacturers India brings the best-quality products. The company carries the rich experience in the niche. Taj Pharmaceuticals is reputed manufacturer and COVID -19 medicines suppliers in India prefer Taj Pharmaceuticals due to the reliability and purity of products. Taj Pharmaceuticals, the well-known COVID -19 medicines Manufacturer in India gives the assurance of high-quality and purity. The stringent quality-control ensure that every batch of the drug brings a consistent standard. As COVID -19 medicines Exporters
With concerns rising about medicine availability during the global COVID-19 coronavirus pandemic, European Pharmaceutical Review explores how the pharmaceutical supply chain is faring
A daily Covid-19 update from Taj Pharmaceuticals Limited Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
A simple glossary of complicated and previously obscure words related to the pandemic. #CoronaVirus #CoronaPrevention #Safety #tajpharmaCorona #CoronaSpread #IndiaFightsCorona #CoronavirusOutbreakindia #CoronavirusPandemic #StaySafeStayHome #IndiaFightsCoronavirus